Methods of treating and detecting cancer using viruses

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S005000, C435S007200, C424S130100, C424S138100, C424S155100, C424S277100, C424S281100, C424S184100, C436S064000

Reexamination Certificate

active

07056689

ABSTRACT:
The invention provides a method of treating cancer in a mammal comprising administering to the mammal an effective amount of virus, particularly Newcastle Disease Virus or other Paramyxovirus. The invention also provides a method of treating cancer in a mammal comprising administering such viruses to the mammal in combination with another agent such as a chemotherapeutic compound, immunoadjuvant, cytokine, or immunosuppressive agent. The invention further provides a method of detecting cancer cells in a mammal using Paramyxovirus as an imaging agent and as an indicator of cancer cell growth in the mammal. The invention further provides genetically engineered Paramyxoviruses, and kits containing the viral compositions disclosed by the invention.

REFERENCES:
patent: 3577525 (1971-05-01), Baker
patent: 4053582 (1977-10-01), Stickl
patent: 4108983 (1978-08-01), Wallack
patent: 4126671 (1978-11-01), House et al.
patent: 4282315 (1981-08-01), Luderer et al.
patent: 4334016 (1982-06-01), Furukawa
patent: 4379839 (1983-04-01), Spiegelman
patent: 4391911 (1983-07-01), Tarro
patent: 4405712 (1983-09-01), Vande Woude et al.
patent: 4465769 (1984-08-01), Hampar et al.
patent: 4571385 (1986-02-01), Greenberg et al.
patent: 4582787 (1986-04-01), Frankel
patent: 4647773 (1987-03-01), Gallo et al.
patent: 4735895 (1988-04-01), Kopelovich
patent: 4748109 (1988-05-01), Baird
patent: 4757000 (1988-07-01), Tohmatsu et al.
patent: 4777127 (1988-10-01), Suni et al.
patent: 4786590 (1988-11-01), McGrath et al.
patent: 4839288 (1989-06-01), Montagnier et al.
patent: 4849334 (1989-07-01), Lorincz
patent: 4861719 (1989-08-01), Miller
patent: 4861720 (1989-08-01), Pedersen et al.
patent: 4908306 (1990-03-01), Lorincz
patent: 4912030 (1990-03-01), Weiss et al.
patent: 4970071 (1990-11-01), McMichael
patent: 5037753 (1991-08-01), Pedersen et al.
patent: 5045447 (1991-09-01), Minson
patent: 5057314 (1991-10-01), Whitfill et al.
patent: 5075213 (1991-12-01), Pande et al.
patent: 5077198 (1991-12-01), Shih et al.
patent: 5124148 (1992-06-01), Csatary et al.
patent: 5142032 (1992-08-01), Grimmel et al.
patent: 5169753 (1992-12-01), Ng et al.
patent: 5192539 (1993-03-01), Van Der Marel et al.
patent: 5215745 (1993-06-01), Csatary et al.
patent: 5252479 (1993-10-01), Srivastava
patent: 5273745 (1993-12-01), Schirrmacher
patent: 5310678 (1994-05-01), Bingham et al.
patent: 5739107 (1998-04-01), Cohen et al.
patent: 2003/0044384 (2003-03-01), Roberts et al.
patent: 2003/0165465 (2003-09-01), Roberts et al.
patent: 0 292 293 (1988-11-01), None
patent: 0 292 293 (1988-11-01), None
patent: 0 292 293 (1988-11-01), None
patent: 58-116422 (1958-07-01), None
patent: 58116422 (1983-07-01), None
patent: 86/00529 (1986-01-01), None
patent: 86/00811 (1986-02-01), None
patent: WO 87/03451 (1987-06-01), None
patent: 93/18790 (1993-09-01), None
patent: 94/21798 (1994-09-01), None
patent: WO 94/18992 (1994-09-01), None
Reichard et al., Journal of Surgical Research 52, 448-453 (1992).
Lorence et al, J. Nan. Cancer Inst. (1988), 80 (16), 1305-12.
Kirn et al. “Replicating viruses as selective cancer therapeutics”. Molecular Medicine Today, 1996, 519-527.
Sharkey et al. in “Experience in Surgical Pathology with Human Tumor Growth in the Nude Mouse”. The Nude Mouse in Experimental and Clinical Research, 1978, chapter 10, pp. 187-214.
National Cancer Institute's complementary and alternative medicine (CAM) on NDV.
Cassel et al. A ten-year follow-up on stage II malignant melanoma patients treated postsurgically with Newcastle disease virus oncolysate. Med Oncol Tumor Pharmacother 9 (4): 169-71, 1992.
Cassel et al. Newcastle Disease virus as an antineoplastic agent. Cancer 18: 863-8, 1965.
Hanson et al. Identification of vaccine strains of Newcastle disease virus. Science, Jul. 1955, vol. 122, p. 156-157.
Cassel et al.,Urologic Oncology, 236-42 (1988).
Cassel et al.,Nat. Immun. Cell Growth Regul., 7, 351-52 (1988).
Csatary et al.,Cancer Detection and Prevention, 17, 619-27 (1993).
Jia et al.,J. Nat'l Cancer Inst., 86, 1209 (1994).
Mineta et al.,Cancer Res., 54, 3963-66 (1994).
Okuna et al.,Biken Journal, 21, 37-49 (1978).
Asada (1974)Cancer, 34, 1907-1928.
Bluming, A.Z. and Ziegler, J.L. (1971)Lancet, 2, 105-106.
Bohle, W., Schlag, P., Liebrich, W., Hohenberger, P., Manasterski, M., Möller, P., and Schirrmacher, V. (1990)Cancer, 66, 1517-1523.
Cascino, C. J. et al. (1992)University Research Week: Apr. 14-16, 1992, Poster No. P54.
Cassel, W. A. and Garrett, R. E. (1965)Cancer, 18, 863-868.
Cassel, W. A., Murray, D. R., & Phillips, H. S. (1983)Cancer, S2, 856-860.
Csatary, L. K. (1971)Lancet, 2, 825.
DePace, N. G. (1912)Ginecologia, 9, 82-88.
Gross, S. (1971)Lancet, 1, 397-398.
Lorence, R. M., et al. (1991)University Research Week: Apr. 16-18, 1991, Poster No. 93.
Lorence, R. M., et al. (1993)Proc. Am. Assoc. Cancer Res., 34, 377.
Lorence, R. M., Reichard, K. W., Cascino, C. J. et al. (1992)Proc. Am. Assoc. Cancer Res., 33, 398.
Murray, D. R., Cassel, W. A., Torbin, A. H., Olkowski, Z. L., & Moore, M. E. (1977)Cancer, 40, 680-686.
Pasquinucci G. (1971)Lancet, 1, 136.
Paulson, J.C., Sadler, J.E. & Hill, R.C. (1979)J. Biol. Chem., 254, 2120-2124.
Reichard, K. W., Lorence, R. M., Katubig, B. B., et al.J. Pediatr. Surg. (in press).
Reichard, K. W., Lorence, R. M., Cascino, C. J., et al. (1992)Surg. Forum, 43, 603-606.
Reichard, K. W. et al. (1992)J. Surg. Res., 52, 448-453.
Reichard, K. W. et al. (1992)Clinical Congress Forum on Fundamental Surgical Problems: Pediatric Surgery, vol. XLIII, pp. 603-606.
Reichard, K. W. et al. (1991)The Association For Academic Surgery: Twenty-fifth Annual Meeting, p. 152.
Reichard, K. W. et al. (1993)University Research Week: Apr. 13-15, 1993, Poster No. 100.
Reichard, K. W. et al. (1992)Proc. Am. Assoc. Cancer Res., 33 521.
Reichard, K. W. et al. (1992)Proc. Am. Assoc. Cancer Res., 33, 521.
Schirrmacher, V. et al. (1986)Cancer Rev., 5, 19-49.
Weiss, S. R. & Bratt, M. A. (1974)J. Virol., 13, 1220-1230.
Austin et al.,Adv. Cancer Res., 30, 301 (1979).
Cassel et al.,Cancer, 40, 672-79 (1977).
Cukor et al.,J. Nat'l Cancer Inst., 55, 957 (1975).
Culver et al.,Science, 256, 1550 (1992).
Dupressoir et al.,Cancer Res., 49, 3203 (1989).
Heicappell et al.,Int. J. Cancer, 37, 569 (1986).
Holzaepfel et al.,Cancer, 10, 577 (1957).
Kenney et al.,J. Nat'l Cancer Inst., 86, 1185 (1994).
Kobayashi,Adv. Cancer Res., 30, 279 (1979).
Lorence et al.,J. Nat'l Cancer Inst., 80, 1305 (1988).
Lorence et al.,J. Nat'l Cancer Inst., 86, 1228 (1994).
Moore,Ann. Rev. Microbiol., 8, 393 (1954).
Ram et al.,Cancer Res., 53, 83-88 (1993).
Reichard, K.W., Lorence, R.M., Katubig, B.B., et al.,J. Pediatr. Surg., 28, 1221 (1993).
Rommelaere et al.,J. Virol. Methods, 33, 233-51 (1991).
Rukavishnikova et al.,Acta Virol., 20, 387 (1976).
Shingu et al.,J. General Virology, 72, 2031 (1991).
Sinkovics et al.,Separatum Experientia, 25, 733 (1969).
Smith et al.,Cancer, 9, 1211 (1956).
Suskind et al.,PSEBM, 94, 309 (1957).
Taylor et al.,J. Nat'l Cancer Inst., 44, 515 (1970).
Telerman et al.,Proc. Natl Acad. Sci. USA, 90, 8702 (1993).
Von Hoegen et al.,Eur. J. Immunol., 18, 1159 (1988).
Walz et al.,J. Virol., 66, 5651 (1992).
Wheelock et al.,New Eng. J. Med., 271, 645 (1964).
Berkner,BioTechniques, 6, 616 (1988).
Bern, inFundamental Virology, pp. 817-837 (2nd ed. 1991).
Bett et al.,J. Virology, 67, 5911 (1993).
Chengalvala et al.,Vaccine, 9, 485.
Di Luca et al.,J. Cancer, 40, 763-68 (1987).
Holzaepel et al.,Cancer, 10, 577 (1957).
Kaufman et al.,New Eng. J. Med., 305, 483 (1981).
Li et al.,Proc. Natl. Acad. Sci., 90, 5214.
Lyerly et al.,Arch. Surg., 128, 1197 (1993).
McDougall et al.,Proc. Natl. Acad. Sci. USA, 79, 3853 (1982).
Millar et al., inNewcastle Disease, pp. 79-97 (Alexander ed. 1988).
Miller et al.,Nature, 357, 455 (1992).
Natuk et al.,Proc. Natl. Acad. Sci., 89, 7777 (1992).
Park et al.,Proc. Natl. Acad. Sci. USA, 88, 5537 (1991).
Pattnaik et al.,Cell, 69, 1011 (1992).
Ramshaw et al.,Immunological Reviews, 127, 157 (1992).
Shingu et al.,J. General Virology, 72, 2031 (1991).
Taniguchi et al.,N

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods of treating and detecting cancer using viruses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treating and detecting cancer using viruses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating and detecting cancer using viruses will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3626152

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.